BIRDS OF A FEATHER: PFIZER AND SANOFI ACQUIRE FELLOW PRICE-GOUGERS IN LATEST BIG PHARMA M&A DEALS
Mar 17, 2023
Big Pharma Giants With Affinity for Price Hikes Acquire Smaller Brand Name… Read More
© 2025 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA WATCH: NEW REPORT HIGHLIGHTS BIG PHARMA’S RAPIDLY RISING LAUNCH PRICES
Mar 10, 2023
Wall Street Journal Analysis Finds Median Monthly Price for Newly Approved… Read More
THEY SAID IT! LAWMAKERS, DRUG PRICING ADVOCATES AND ECONOMIC EXPERTS CALL FOR SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Mar 10, 2023
Event Highlights Importance of Holding Big Pharma Accountable to Boost… Read More
BIG PHARMA WATCH: NYT REPORT DOCUMENTS NARCOLEPSY DRUG MAKER’S EGREGIOUS EXPLOITATION OF PATENT SYSTEM
Feb 28, 2023
Anti-Competitive Strategy Around Brand Name Narcolepsy Medications Blocked… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE AND ASTRAZENECA
Feb 28, 2023
Big Pharma Giants Once Again Top Wall Street Expectations in Final Round of… Read More
BIG PHARMA EARNINGS WATCH: MERCK, SANOFI, BRISTOL-MYERS SQUIBB AND ELI LILLY
Feb 21, 2023
Four Big Pharma Giants That Hiked Drug Prices on American Patients in 2022 and… Read More
DOSE OF REALITY: BIG PHARMA IS THE CULPRIT BEHIND OUT-OF-CONTROL PRESCRIPTION DRUG PRICES
Feb 16, 2023
Lawmakers Should Focus Attention on Brand Name Drug Companies That Set Prices,… Read More
THEY SAID IT! SENATORS HIGHLIGHT URGENCY TO HOLD BIG PHARMA ACCOUNTABLE TO LOWER DRUG PRICES
Feb 13, 2023
Senate Judiciary Committee Advances Bipartisan Legislation Cracking Down on… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, AMGEN, GLAXOSMITHKLINE, NOVARTIS AND JOHNSON & JOHNSON
Feb 6, 2023
Brand Name Drug Companies Kick Off Q4 Earnings Calls After More than 600 Price… Read More
DOSE OF REALITY: SENATE HEARING PROVIDES OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS PATENT ABUSE
Feb 2, 2023
Critical Legislation Targets Anti-Competitive Practices like Patent Thickets… Read More
DOSE OF REALITY: BIG PHARMA’S PATENT THICKETS COST PATIENTS AND TAXPAYERS BILLIONS IN LOST SAVINGS EACH YEAR
Jan 26, 2023
New Matrix Global Advisors Report Shines Light on Cost of Big Pharma’s… Read More
BIG PHARMA WATCH: BIG PHARMA SET RECORD FOR OUT-OF-CONTROL LAUNCH PRICES IN 2022 AS MEDIAN PRICE OF NEW TREATMENTS SURGED PAST $220,000
Jan 6, 2023
Brand Name Drug Companies Setting Egregious Prices on New Products Not… Read More